Adial Pharmaceuticals, Inc (ADIL)
Adial Pharmaceuticals, Inc (ADIL)
$1.96 USD
Updated Jul 19 12:00am
Add ADIL to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 213 in Medical - Pharmaceuticals
See all “A” rated Strong Buy stocks
ADIL News Stream
| Event/Time | News Detail | Start | End | Change | |||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Top Stories View All
Best & Worst Performing Stock Industries for July 19, 2019
Best & Worst Performing Small Cap Stocks for July 19, 2019
Best & Worst Performing Mid Cap Stocks for July 19, 2019
Best & Worst Performing Mega Cap Stocks for July 19, 2019
Best & Worst Performing Large Cap Stocks for July 19, 2019
View All Top StoriesAdial Pharmaceuticals, Inc (ADIL) Company Bio
Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic agents for the treatment of alcohol use disorders in the United States. Its lead product is AD04, a selective serotonin-3 antagonist that has completed Phase IIb clinical trials for the treatment of nausea and emesis. The company was founded in 2010 and is based in Charlottesville, Virginia.
ADIL Stock Chart More Charts
ADIL Price/Volume Stats
| Current price | $1.96 |
| Prev. close | $2.01 |
| Day low | $1.90 |
| Day high | $2.04 |
| 50-day MA | $2.01 |
| 200-day MA | $3.13 |
| 52-week high | $9.44 |
| 52-week low | $1.11 |
| Volume | 13,700 |
| Avg. volume | 288,547 |
| Dividend yield | N/A |
| Market Cap | 20.04M |
ADIL Returns
| 1-mo | 0.51% |
| 3-mo | -27.14% |
| 6-mo | -66.21% |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | N/A |
| YTD | -61.72% |
| 2018 | N/A |
| 2017 | N/A |
| 2016 | N/A |
| 2015 | N/A |
| 2014 | N/A |
Loading social stream, please wait...